Question to the Department for Science, Innovation & Technology:

To ask His Majesty's Government what support they are providing to UK life sciences and investment in the innovation pipeline to build on recent successes such as the development of a malaria vaccine by the Oxford-based Jenner Institute.

The UK has an exceptional life sciences sector, and the UK Government is committed to supporting it. We work closely with industry, including through strategic partnerships, such as the 10-year partnership with Moderna and strategic collaboration with BioNTech, delivering innovation to UK patients.

Following the Life Sciences Vision launched in 2022, we announced in May a further £650m to drive growth and bring innovative treatments to the NHS, including £121m to improve commercial clinical trials, £48m for a new biomanufacturing fund, and £154m to increase the capacity of the UK Biobank.